Pfizer · NSE: PFIZER · BSE: 500680
Q2 FY22 results · Jul–Sep 2021
Pfizer reported revenue from operations of ₹636.26 crore (up 6.9% from Q2 FY21) and net profit of ₹142.95 crore (up 8.8% from Q2 FY21) for Q2 FY22 (Jul–Sep 2021), on a standalone basis.
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 636.26 | 595.41 | +6.9% | 749.17 | −15.1% |
| Other income | 15.03 | 12.15 | +23.7% | 12.24 | +22.8% |
| Total income | 651.29 | 607.56 | +7.2% | 761.41 | −14.5% |
| Profit before tax | 174.96 | 183.03 | −4.4% | 268.73 | −34.9% |
| Net profit for the period | 142.95 | 131.37 | +8.8% | 199.91 | −28.5% |
| EPS, basic (₹) | 31.25 | 28.71 | +8.8% | 43.69 | −28.5% |
| Net margin (%) | 22.5 | 22.1 | 26.7 |
Standalone
- Filed with BSE
- 03 Nov 2021, 18:54 IST
- Board meeting
- 03 Nov 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE